Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine Open-label Extension in RLS
NCT00498108Phase 3Completed
- Sponsor
- UCB
- Start
- Jan 2006
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rotigotine in restless legs syndrome (RLS), sponsored by UCB. Started Jan 2006; status: completed.
02
Drugs
rotigotine
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00498108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00498108.